Cas No.: 199807-33-5
PRODUCT INFORMATION
Description
Cyclo(Arg-Gly-Asp-D-Phe-Val) TFA, also known as Cyclo(RGDfV), is a potent and selective inhibitor of integrin αvβ3. It has demonstrated cytotoxic properties in certain in vitro systems and is often used as a standard research tool in the study of integrin-mediated processes, particularly in acute myeloid leukemia (AML) cell models where this integrin is overexpressed.
Molecular Weight
688.65
Purity
> 95%
Formula
C₂₈H₃₉F₃N₈O₉
Product Type
Targeting Peptide
Sequence
Cyclo[Arg-Gly-Asp-D-Phe-Val]
Form (20 deg.C)
Solid
Storage Condition
Store sealed at -20°C, away from moisture.
For Research Use Only | Not For Clinical Use
Related products
- Cyclic SSTR Agonist Octreotide (CAT#: OLY-1025-YS-39)
- Cyclo(Arg-Gly-Asp-D-Phe-Cys) TFA Targeting Peptide (CAT#: OLY-1025-YS-68)
- Thrombin-cleavable Targeting Peptide (CAT#: OLY-1025-YS-34)
- rTAT Targeting Peptide (CAT#: OLY-1025-YS-20)
- GB-6 Targeting Peptide (CAT#: OLY-1025-YS-11)
- FFAGLDD TFA Targeting Peptide (CAT#: OLY-1025-YS-49)
- CXCL9(74-103) Targeting Peptide (CAT#: OLY-1025-YS-42)
- IETP2 Targeting Peptide (CAT#: OLY-1025-YS-30)
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.